Reactive arthritis is one of the spondyloarthropathy family of clinical syndromes. The clinical features are those shared by other members of the spondyloarthritis family, though it is distinguished by a clear relationship with a precipitating infection. Susceptibility to reactive arthritis is closely linked with the class 1 HLA allele B27; it is likely that all sub-types pre-dispose to this condition. The link between HLA B27 and infection is mirrored by the development of arthritis in HLA B27-transgenic rats. In this model, arthritis does not develop in animals maintained in a germ-free environment.
Infections of the gastrointestinal, genitourinary and respiratory tract appear to provoke reactive arthritis and a wide range of pathogens has now been implicated. Although mechanistic parallels may exist, reactive arthritis is distinguished from Lyme disease, rheumatic fever and Whipple’s disease by virtue of the distinct clinical features and the link with HLA B27. As in these conditions both antigens and DNA of several micro-organisms have been detected in joint material from patients with reactive arthritis. The role of such disseminated microbial elements in the provocation or maintenance of arthritis remains unclear. HLA B27-restricted T-cell responses to microbial antigens have been demonstrated and these may be important in disease pathogenesis. The importance of dissemination of bacteria from sites of mucosal infection and their deposition injoints has yet to be fully understood.
The role of antibiotic therapy in the treatment of reactive arthritis is being explored; in some circumstances, both the anti-inflammatory and anti-microbial effects of certain antibiotics appear to be valuable.
The term reactive arthritis should be seen as a transitory one, reflecting a concept which may itselfbe on the verge of replacement, as our understanding of the condition develops. Nevertheless it appropriately describes arthritis that is associated with demonstrable infection at a distant site without traditional evidence of sepsis at the affected joint(s).
Although several forms of disease could be described as “reactive”, particularly acute rheumatic fever, post-meningococcal septicaemia arthritis and Lyme disease, in clinical practice the term is restricted to an acute spondyloarthritis, usually, but not exclusively, linked to acute genitourinary or gastrointestinal infection. A proportion of patients fulfil criteria for Reiter’s Syndrome .
KeywordsLyme Disease Chlamydia Trachomatis Rheumatic Fever Reactive Arthritis Acute Rheumatic Fever
Unable to display preview. Download preview PDF.
- 2.Moll JMH, Haslock I, Macrae I, Wright V. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies and Behçet’s syndrome. Medicine (Baltimore) 53, 343–1974Google Scholar
- 3.Dougados M, Van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Catz A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34, 1218–1227. 1991PubMedCrossRefGoogle Scholar
- 4.Toivanen A. Reactive arthritis and Reiter’s syndrome: history and clinical features. Rheumatology, eds JH Klippel, PA Dieppe. Mosby, London 11, 1–8. 1997Google Scholar
- 6.Fink CW. The role of the streptococcus in post-streptococcal reactive arthritis and childhood polyarthritis nodosa. J Rheumatol 18 (Suppl) 14–20. 1991Google Scholar
- 9.Braun J, Laitko S, Treharne J, Eggens U, Wu P, Distler A, Sieper J. Chlamydia pneumoniae — a new causative agent of reactive arthritis and undifferentiated oligoarthritis.Google Scholar
- 11.Silveira LH, Gutierrez F, Scopelitis E, Cuellar ML, Citera G & Espinoza LR. Chlamydia-induced reactive arthritis. Rheum Dis Clin N Amer 19, 351–362. 1993Google Scholar
- 14.Taylor-Robinson D, Thomas BJ, Furr PM, Keat AC. The association of Mycoplasma hominis with arthritis. Sex Trans Dis (Suppl) 10, 341–344. 1983Google Scholar
- 18.Rahman MU, Hudson AP, Schumacher HR. Chlamydia and Reiter’s Syndrome (reactive arthritis). Rheum Dis Clin N Amer 18, 16–79. 1992Google Scholar
- 20.Branigan PJ, Gerard HC, Saaibi D, Hudson AP, Schumacher HR. Screening of synovial tissue versus fluid from patients with Reiter’s Syndrome (RS), other spondyloarthropathies or reactive arthritis (ReA) for chlamydia via polymerase chain reaction (PCR). Arthritis Rheum 38(R20). 1995Google Scholar
- 22.Li F, Bulbul R, Schumacher HR, Kieber-Emmons T, Callegari PE, Von Feldt JM, Norden D, Freundlich B, Wang B, Imonitie V, Peichang C, Nachamkin I, Weiner DB, Williams VW. Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum 39, 950–958. 1996PubMedCrossRefGoogle Scholar
- 23.Lahesmaa-Rantala R, Granfors K, Isomaki H, Toivanen A. Yersinia-specific immune complexes in the synovial fluid of patients with Yersinia-triggered reactive arthritis. Ann Rheum Dis 46, 510=514. 1987Google Scholar
- 24.Hughes RA, Keat AC. Reactive arthritis: the role of bacterial antigens in inflammatory arthritis. Clin Rheum 6, 285–308. 1992Google Scholar